N07.A
Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Hereditary nephropathy, not elsewhere classified with C3 glomerulopathy
Excludes Type 1
- Hereditary nephropathy, not elsewhere classified (with C3 glomerulopathy) with dense deposit disease (N07.6)
Medical Intelligence & Overview
Hereditary nephropathy with C3 glomerulonephritis is a rare genetic kidney disorder characterized by inherited damage to the kidneys' filtering units. This condition involves abnormal immune activity within the glomeruli, leading to inflammation and progressive loss of kidney function. Early recognition and management are crucial to prevent severe kidney damage and potential failure.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from family members that affect immune system regulation within the kidneys Altered regulation of the complement system, leading to overactivation in the kidney tissues Family history of kidney disease or similar conditions
Key Symptoms: Blood in the urine (hematuria) Protein in the urine (proteinuria) Swelling in the legs, ankles, or around the eyes (edema) High blood pressure (hypertension) Repeated urinary tract infections Decreased urine output in advanced stages Fatigue and general malaise
Diagnostic & Treatment
Diagnosis Path: Diagnosing hereditary nephropathy with C3 glomerulonephritis involves a combination of clinical evaluation, laboratory tests, and kidney biopsy. Key diagnostic approaches include: - Blood tests to assess kidney function, such as serum creatinine and estimated glomerular filtration rate (eGFR) - Urinalysis to detect blood and protein in urine - Genetic testing to identify specific inherited mutations - Kidney biopsy to examine tissue under a microscope, revealing characteristic patterns of inflammation and immune deposits, especially C3 complement deposits - Imaging studies like ultrasound to evaluate kidney size and structure Accurate diagnosis helps differentiate this condition from other types of glomerulonephritis and guides appropriate management.
Treatment Protocols: Management of this hereditary kidney disorder focuses on slowing disease progression, controlling symptoms, and preventing complications. Typical treatments include: - Blood pressure control with medications such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) - Immunosuppressive therapies in specific cases to reduce immune activity - Regular monitoring of kidney function and urine analysis - Dietary modifications to reduce salt intake and manage fluid balance - Addressing complications like edema or anemia - In some cases, preparation for kidney replacement therapy (dialysis or transplantation) may become necessary as the disease advances - Genetic counseling for affected families Because this is a hereditary condition, ongoing medical care and family screening are important components of overall management.
Clinical Advice & FAQs
Billing Guidance
Is N07.A a billable ICD-10 code?
Yes, N07.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N07.A?
Clinical documentation must specify the nature of Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference